Financial

M. Ragan Hart joins Washington Research Foundation as senior associate for strategic investments

Investor brings more than a decade of life-sciences experience to WRF, specializing in health economics, diagnostics, artificial intelligence, machine learning…

4 months ago

Spring Health Wins Stevie® Award for Technical Innovation

Recognized among more than 1,500 global entries for using data-driven technology to improve outcomes and reduce employer healthcare costs NEW…

4 months ago

Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools

Results highlight the role of artificial intelligence development in enabling earlier detection of aortic stenosis. The Company announces new Aorta…

4 months ago

Yatiri Bio Acquires NGeneBioAI to Expand AI-Powered Proteomics Platform and Advance Precision Biomarker Discovery

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio, Inc., a leader in proteomics-driven precision medicine, today announced the…

4 months ago

Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)…

4 months ago

LUMEXA IMAGING NAMES RADIOLOGIST DR. RUSSELL STEWART AS CHIEF MEDICAL OFFICER

RALEIGH, N.C., Aug. 4, 2025 /PRNewswire/ -- Lumexa Imaging, one of the nation's largest providers of outpatient imaging services, today…

4 months ago

Advarra Appoints Brian Hart as Chief Technology Officer

Former Covera Health CTO to Lead Technology and Product Strategy, Driving Innovation in Clinical Research COLUMBIA, Md., Aug. 4, 2025…

4 months ago

Healthcare Leaders Address Economic, Regulatory, and Sustainability Challenges Ahead of AHRMM25

Insights from Black Book's 12th Annual Healthcare Supply Chain and Purchasing Technology Leadership Surveys DENVER, CO / ACCESS Newswire /…

4 months ago

CORRECTING and REPLACING Butterfly Network Reports Second Quarter 2025 Financial Results

Delivered Highest Quarterly Revenue and Gross Margins in Company History  Quarterly Revenue of $23.4 million in Q2, representing 9% YoY…

4 months ago

Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

BURLINGTON, Mass., July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a…

4 months ago